Read the policies, reports, and plans on how we address issues like racism and reduce our carbon footprint, ensuring our actions align with the highest ethical standards.
In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.
We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.
Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.
Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.
Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.
This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.
This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.
This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.
BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.
Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.
Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.
Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.
MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.
The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.
The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.
The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.
A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.
Noma is a preventable and treatable neglected disease, but 90 per cent of people will die within the first two weeks of infection if they do not receive treatment.
This page is no longer being maintained and was last updated in December 2021.
On 16 December 2021, DRC declared the country’s thirteenth recorded outbreak of Ebola over.
The outbreak, which was located in DRC’s northeast, in North Kivu province, was declared on 8 October. This thirteenth outbreak came five months after the end of the twelfth outbreak, also in North Kivu province. It was the country’s fifth outbreak since May 2018.
MSF teams responded to the outbreak in North Kivu.
Vaccination halves mortality among people infected with Ebola
Press Release8 Feb 2024
DRC Ebola outbreaks
DRC's thirteenth Ebola outbreak
Crisis Update20 Dec 2021
DRC Ebola outbreaks
DRC's twelfth Ebola outbreak
Crisis Update7 May 2021
DRC Ebola outbreaks
MSF responds in North Kivu to twelfth Ebola outbreak in DRC
Project Update25 Feb 2021
DRC Ebola outbreaks
Improved medical response sees the end of DRC’s eleventh Ebola outbreak
Project Update19 Nov 2020
DRC Ebola outbreaks
New strategies at work in eleventh Ebola outbreak in DRC
Interview4 Nov 2020
DRC Ebola outbreaks
DRC's eleventh Ebola outbreak
Crisis Update3 Nov 2020
DRC Ebola outbreaks
Responding to new Ebola outbreak in Équateur province
Project Update4 Sep 2020
DRC Ebola outbreaks
Six lessons learned as Ebola outbreak in northeastern DRC ends
Project Update26 Jun 2020
DRC Ebola outbreaks
DRC's tenth Ebola outbreak
Crisis Update25 Jun 2020
DRC Ebola outbreaks
New Ebola cases confirmed in DRC days before expected end of outbreak
Project Update23 Apr 2020
DRC Ebola outbreaks
How the Ebola response failed the people of DRC
Opinion24 Mar 2020
Related topics
Democratic Republic of Congo
In DRC, MSF runs some of its largest medical relief operations, working in 17 of 26 provinces, responding to diseases outbreaks, conflict and displacement, and tackling health problems such as HIV/AIDs.
Medical activities
Haemorrhagic fevers
Ebola and Marburg haemorrhagic fevers are rare but deadly. Outbreaks can kill 25 to 90 per cent of those infected, spreading fear and panic among affected communities.
Crisis settings
Epidemics and pandemics
Millions of people still die each year from infectious diseases that are preventable or can be treated.
